Targeted therapy for malignant glioma patients: lessons learned and the road ahead.

Targeted therapy for malignant glioma patients: lessons learned and the road ahead.
复制标题

DOI:
10.1016/j.nurt.2009.04.008
复制
发表时间:
2009-07
期刊:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
影响因子:
--
通讯作者:
Mischel PS
Mischel PS
中科院分区:
其他
文献类型:
--
作者:
Huang TT;Sarkaria SM;Cloughesy TF;Mischel PS

文献摘要

参考文献

被引文献

相似文献

分子靶向治疗正在改变恶性胶质瘤患者的护理,包括胶质母细胞瘤,成人最常见的恶性原发性脑肿瘤。随着小分子抑制剂和抗体的武库,目标是信号转导机制的关键组成部分,通常在神经胶质瘤中激活,神经肿瘤学家和神经外科医生准备改变这些患者的护理。然而,靶向治疗的成功应用仍然是一个挑战。缺乏将激酶抑制剂或其他途径特异性疗法导向最有可能受益的个体患者的策略。此外,对靶向药物的反应不仅取决于关键突变激酶的存在,还取决于癌细胞分子回路中的其他关键变化;例如,关键肿瘤抑制蛋白的丢失、激酶抗性突变体的选择和反馈环的失调。了解这些网络,并在患者中研究它们,对于开发合理的联合疗法以抑制恶性胶质瘤患者的耐药性至关重要。本文就恶性胶质瘤分子靶向治疗的研究现状作一综述。我们最初专注于确定迄今为止从靶向患者的EGFR/PI 3 K/Akt/mTOR信号通路中学到的一些见解,以及这如何导致靶向治疗的一些新挑战和新方向的重新概念化。我们描述了来自基因组学世界的新进展如何有潜力改变我们的靶向治疗方法,并描述了如何更深入地了解癌症的复杂性质,其擅长重新布线分子电路以逃避靶向药物,提出了新的挑战并确定了新的线索。
Molecularly targeted therapies are transforming the care of patients with malignant gliomas, including glioblastoma, the most common malignant primary brain tumor of adults. With an arsenal of small molecule inhibitors and antibodies that target key components of the signal transduction machinery that are commonly activated in gliomas, neuro-oncologists and neurosurgeons are poised to transform the care of these patients. Yet, the successful application of targeted therapies remains a challenge. Strategies are lacking for directing kinase inhibitor or other pathway-specific therapies to individual patients most likely to benefit. In addition, response to targeted agents is determined not only by the presence of the key mutant kinases, but also by other critical changes in the molecular circuitry of cancer cells; e.g. such as loss of key tumor suppressor proteins, the selection for kinase resistant mutants and the deregulation of feedback loops. Understanding these networks, and studying them in patients, will be critical for developing rational combination therapies to suppress resistance for malignant glioma patients. Here we review the current status of molecular targeted therapies for malignant gliomas. We focus initially on identifying some of the insights learned so far from targeting the EGFR/PI3K/Akt/mTOR signaling pathway in patients and on how this has lead towards a re-conceptualization of some of the new challenges and new directions for targeted treatment. We describe how new advances from the world of genomics have the potential to transform our approach towards targeted therapies, and describe how a deeper understanding of the complex nature of cancer, its adeptness at re-wiring molecular circuitry to evade targeted agents, has raised new challenges and identified new leads.
雷帕霉素在I期试验中针对复发性PTEN缺陷型胶质母细胞瘤患者的抗肿瘤活性。
DOI: 10.1371/journal.pmed.0050008
发表时间: 2008-01-22
期刊: PLOS MEDICINE
影响因子: 15.8
作者:
Cloughesy, Tim F.;Yoshimoto, Koji;Nghiemphu, Phioanh;Brown, Kevin;Dang, Julie;Zhu, Shaojun;Hsueh, Teli;Chen, Yinan;Wang, Wei;Youngkin, David;Liau, Linda;Martin, Neil;Becker, Don;Bergsneider, Marvin;Lai, Albert;Green, Richard;Oglesby, Tom;Koleto, Michael;Trent, Jeff;Horvath, Steve;Mischel, Paul S.;Mellinghoff, Ingo K.;Sawyers, Charles L.
通讯作者: Sawyers, Charles L.
DOI: 10.1158/1078-0432.ccr-07-1810
发表时间: 2008-02-15
影响因子: 11.5
作者:
Brandes, Alba A.;Franceschi, Enrico;Stupp, Roger
通讯作者: Stupp, Roger
DOI: 10.1016/s1535-6108(02)00046-6
发表时间: 2002-04-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Bachoo, RM;Maher, EA;DePinho, RA
通讯作者: DePinho, RA
DOI: 10.1038/nature07385
发表时间: 2008-10-23
期刊: NATURE
影响因子: 64.8
作者:
Chin, L.;Meyerson, M.;Aldape, K.;Bigner, D.;Mikkelsen, T.;VandenBerg, S.;Kahn, A.;Penny, R.;Ferguson, M. L.;Gerhard, D. S.;Getz, G.;Brennan, C.;Taylor, B. S.;Winckler, W.;Park, P.;Ladanyi, M.;Hoadley, K. A.;Verhaak, R. G. W.;Hayes, D. N.;Spellman, Paul T.;Absher, D.;Weir, B. A.;Ding, L.;Wheeler, D.;Lawrence, M. S.;Cibulskis, K.;Mardis, E.;Zhang, Jinghui;Wilson, R. K.;Donehower, L.;Wheeler, D. A.;Purdom, E.;Wallis, J.;Laird, P. W.;Herman, J. G.;Schuebel, K. E.;Weisenberger, D. J.;Baylin, S. B.;Schultz, N.;Yao, Jun;Wiedemeyer, R.;Weinstein, J.;Sander, C.;Gibbs, R. A.;Gray, J.;Kucherlapati, R.;Lander, E. S.;Myers, R. M.;Perou, C. M.;McLendon, Roger;Friedman, Allan;Van Meir, Erwin G;Brat, Daniel J;Mastrogianakis, Gena Marie;Olson, Jeffrey J;Lehman, Norman;Yung, W. K. Alfred;Bogler, Oliver;Berger, Mitchel;Prados, Michael;Muzny, Donna;Morgan, Margaret;Scherer, Steve;Sabo, Aniko;Nazareth, Lynn;Lewis, Lora;Hall, Otis;Zhu, Yiming;Ren, Yanru;Alvi, Omar;Yao, Jiqiang;Hawes, Alicia;Jhangiani, Shalini;Fowler, Gerald;San Lucas, Anthony;Kovar, Christie;Cree, Andrew;Dinh, Huyen;Santibanez, Jireh;Joshi, Vandita;Gonzalez-Garay, Manuel L.;Miller, Christopher A.;Milosavljevic, Aleksandar;Sougnez, Carrie;Fennell, Tim;Mahan, Scott;Wilkinson, Jane;Ziaugra, Liuda;Onofrio, Robert;Bloom, Toby;Nicol, Rob;Ardlie, Kristin;Baldwin, Jennifer;Gabriel, Stacey;Fulton, Robert S.;McLellan, Michael D.;Larson, David E.;Shi, Xiaoqi;Abbott, Rachel;Fulton, Lucinda;Chen, Ken;Koboldt, Daniel C.;Wendl, Michael C.;Meyer, Rick;Tang, Yuzhu;Lin, Ling;Osborne, John R.;Dunford-Shore, Brian H.;Miner, Tracie L.;Delehaunty, Kim;Markovic, Chris;Swift, Gary;Courtney, William;Pohl, Craig;Abbott, Scott;Hawkins, Amy;Leong, Shin;Haipek, Carrie;Schmidt, Heather;Wiechert, Maddy;Vickery, Tammi;Scott, Sacha;Dooling, David J.;Chinwalla, Asif;Weinstock, George M.;O'Kelly, Michael;Robinson, Jim;Alexe, Gabriele;Beroukhim, Rameen;Carter, Scott;Chiang, Derek;Gould, Josh;Gupta, Supriya;Korn, Josh;Mermel, Craig;Mesirov, Jill;Monti, Stefano;Nguyen, Huy;Parkin, Melissa;Reich, Michael;Stransky, Nicolas;Garraway, Levi;Golub, Todd;Protopopov, Alexei;Perna, Ilana;Aronson, Sandy;Sathiamoorthy, Narayan;Ren, Georgia;Kim, Hyunsoo;Kong, Sek Won;Xiao, Yonghong;Kohane, Isaac S.;Seidman, Jon;Cope, Leslie;Pan, Fei;Van Den Berg, David;Van Neste, Leander;Yi, Joo Mi;Li, Jun Z.;Southwick, Audrey;Brady, Shannon;Aggarwal, Amita;Chung, Tisha;Sherlock, Gavin;Brooks, James D.;Jakkula, Lakshmi R.;Lapuk, Anna V.;Marr, Henry;Dorton, Shannon;Choi, Yoon Gi;Han, Ju;Ray, Amrita;Wang, Victoria;Durinck, Steffen;Robinson, Mark;Wang, Nicholas J.;Vranizan, Karen;Peng, Vivian;Van Name, Eric;Fontenay, Gerald V.;Ngai, John;Conboy, John G.;Parvin, Bahram;Feiler, Heidi S.;Speed, Terence P.;Socci, Nicholas D.;Olshen, Adam;Lash, Alex;Reva, Boris;Antipin, Yevgeniy;Stukalov, Alexey;Gross, Benjamin;Cerami, Ethan;Wang, Wei Qing;Qin, Li-Xuan;Seshan, Venkatraman E.;Villafania, Liliana;Cavatore, Magali;Borsu, Laetitia;Viale, Agnes;Gerald, William;Topal, Michael D.;Qi, Yuan;Balu, Sai;Shi, Yan;Wu, George;Bittner, Michael;Shelton, Troy;Lenkiewicz, Elizabeth;Morris, Scott;Beasley, Debbie;Sanders, Sheri;Sfeir, Robert;Chen, Jessica;Nassau, David;Feng, Larry;Hickey, Erin;Schaefer, Carl;Madhavan, Subha;Buetow, Ken;Barker, Anna;Vockley, Joseph;Compton, Carolyn;Vaught, Jim;Fielding, Peter;Collins, Francis;Good, Peter;Guyer, Mark;Ozenberger, Brad;Peterson, Jane;Thomson, Elizabeth
通讯作者: Thomson, Elizabeth
DOI: 10.1016/j.ccr.2006.11.023
发表时间: 2007-02-01
期刊: CANCER CELL
影响因子: 50.3
作者:
Bruna, Alejandra;Darken, Rachel S.;Seoane, Joan
通讯作者: Seoane, Joan